Jermasek Douglas 4
4 · Unicycive Therapeutics, Inc. · Filed Nov 23, 2022
Insider Transaction Report
Form 4
Jermasek Douglas
EVP of Corporate Strategy
Transactions
- Award
Stock Options
2022-11-21+55,000→ 155,000 totalExercise: $0.75Exp: 2032-11-21→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]13,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.